Safety and effectiveness of risdiplam in adults with spinal muscular atrophy: a systematic review
{{output}}
Background: Risdiplam has broadened therapeutic options for spinal muscular atrophy (SMA). While its efficacy and safety are well established in children, data in adults remain limited. This review summarizes current evidence on ... ...
